Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-9.0M $-1.3M $-738.4K $-65.8K $-32.2K $-13.3K $-11.7K
Depreciation & Amortization
Depreciation $19.3K $345 $86 $0
Amortization
Stock-Based Compensation $5.8M $0 $268.0K
Net Cash from Operating Activities $-881.5K $-548.2K $-446.5K $-62.5K $-30.0K $-8.7K $-12.9K
Investing Activities
Capital Expenditures $45.1K $26.3K $1.7K
Business Acquisitions
Net Cash from Investing Activities $-45.1K $-20.1K $-7.9K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $940.0K $557.0K $491.7K $46.8K $42.0K $0 $25.0K
Net Change in Cash
Free Cash Flow $-926.7K $-574.5K $-448.2K
← Newer Page 2 of 2 Older →